Literature DB >> 938174

Tickborne oculoglandular tularemia: case report and review of seasonal and vectorial associations in 106 cases.

R L Guerrant, M K Humphries, J E Butler, R S Jackson.   

Abstract

A patient acquired tickborne oculoglandular tularemia in early summer in rural Virginia. Tick exposure may be a clue to the diagnosis of tularemia in the eastern as well as the western United States, especially in summer months. A review of the experience with tularemia in Virginia for the last 13 years shows a bimodal seasonal incidence of tularemia with an associated vector exposure in 77.4% of 106 cases. The majority of cases occurring during winter months have been associated with rabbit exposure, while those in summer months are often associated with tick exposure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938174     DOI: 10.1001/archinte.136.7.811

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Cat-scratch disease presenting as the oculoglandular syndrome of Parinaud: a report of two cases.

Authors:  A S Jawad; A A Amen
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

2.  "Muskrat fever": two outbreaks of tularemia near Montreal.

Authors:  L Ford-Jones; G Delage; K R Powell; G A Ahronheim; E Rousseau; F Gosselin
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

3.  The potential for flower nectar to allow mosquito to mosquito transmission of Francisella tularensis.

Authors:  Adam Kenney; Austin Cusick; Jessica Payne; Anna Gaughenbaugh; Andrea Renshaw; Jenna Wright; Roger Seeber; Rebecca Barnes; Aleksandr Florjanczyk; Joseph Horzempa
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

4.  Real-time PCR for diagnosis of oculoglandular tularemia.

Authors:  Max Maurin; Bernard Castan; Nathalie Roch; Brieuc Gestin; Isabelle Pelloux; Alexandra Mailles; Christophe Chiquet; Pascal Chavanet
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.